Skip to main content
Erschienen in: Pediatric Nephrology 5/2003

01.05.2003 | Original Article

Adrenomedullin and nitric oxide in children with detrusor instability

verfasst von: Ayşe Balat, Kemal Sarıca, Mustafa Çekmen, Muhittin Yürekli, Faruk Yağcı, Ahmet Erbağcı

Erschienen in: Pediatric Nephrology | Ausgabe 5/2003

Einloggen, um Zugang zu erhalten

Abstract.

Detrusor instability (DI) and detrusor-external sphincter dyssynergia lead to poor bladder emptying and high bladder pressure. Recent results indicate that nitric oxide (NO) is an important transmitter or messenger molecule in autonomic neurotransmission. Adrenomedullin (AM) is a potent vasodilator and natriuretic peptide, originally purified from human pheochromocytoma. Since NO and AM have vasodilatory effects on smooth muscles, we considered them to be of interest in children with DI. We determined the tissue levels of NO and AM in 14 children with DI, and compared these with 6 children with normal bladder activity. Bladder biopsy total nitrite levels (nmol/g tissue) were decreased in children with DI (10.69±0.91 vs. 12.83±0.98, P<0.01). However, AM levels (pmol/g tissue) were increased in the same patients (48.84±3.52 vs. 28.79±1.53, P<0.001). According to our results, decreased NO production probably has a role in the pathophysiology of DI, although increased AM appears to be compensatory. NO may provide a therapeutic target in clinical situations related to DI. However, the functional significance of AM and NO in bladder smooth muscle remains to be determined by further detailed studies.
Literatur
1.
Zurück zum Zitat Hinman F (1986) Non-neurologic bladder (the Hinman syndrome) 15 years later. J Urol 136:769–771PubMed Hinman F (1986) Non-neurologic bladder (the Hinman syndrome) 15 years later. J Urol 136:769–771PubMed
2.
Zurück zum Zitat Feng WC, Churchill BM (2001) Dysfunctional elimination syndrome in children without obvious spinal cord diseases. Pediatr Clin North Am 48:1489–1504PubMed Feng WC, Churchill BM (2001) Dysfunctional elimination syndrome in children without obvious spinal cord diseases. Pediatr Clin North Am 48:1489–1504PubMed
3.
Zurück zum Zitat deGroat WC, Saum WR (1976) Synaptic transmission in parasympathetic ganglia in the urinary bladder of the cat. J Physiol 256:137–158PubMed deGroat WC, Saum WR (1976) Synaptic transmission in parasympathetic ganglia in the urinary bladder of the cat. J Physiol 256:137–158PubMed
4.
Zurück zum Zitat Buga GM, Ignarro LJ (1992) Electrical field stimulation causes endothelium-dependent nitric oxide-mediated relaxation of pulmonary artery. Am J Physiol 262:H973–H979PubMed Buga GM, Ignarro LJ (1992) Electrical field stimulation causes endothelium-dependent nitric oxide-mediated relaxation of pulmonary artery. Am J Physiol 262:H973–H979PubMed
5.
Zurück zum Zitat Bush PA, Aronson WJ, Buga GM, Rajfer J, Ignarro LJ (1992) Nitric oxide is a potent relaxant of human and rabbit corpus cavernosum. J Urol 147:1650–1655PubMed Bush PA, Aronson WJ, Buga GM, Rajfer J, Ignarro LJ (1992) Nitric oxide is a potent relaxant of human and rabbit corpus cavernosum. J Urol 147:1650–1655PubMed
6.
Zurück zum Zitat Li CG, Rand MJ (1990) Nitric oxide and vasoactive intestinal polypeptide mediate nonadrenergic noncholinergic inhibitory transmission to smooth muscle of the rat gastric fundus. Eur J Pharmacol 191:303–309PubMed Li CG, Rand MJ (1990) Nitric oxide and vasoactive intestinal polypeptide mediate nonadrenergic noncholinergic inhibitory transmission to smooth muscle of the rat gastric fundus. Eur J Pharmacol 191:303–309PubMed
7.
Zurück zum Zitat Moncada S, Palmer RMJ, Higgs EA (1991) Nitric oxide: physiology, patho-physiology and pharmacology. Pharmacol Rev 43:109–142PubMed Moncada S, Palmer RMJ, Higgs EA (1991) Nitric oxide: physiology, patho-physiology and pharmacology. Pharmacol Rev 43:109–142PubMed
8.
Zurück zum Zitat Mamas MA, Reynard JM, Brading AF (2001) Augmentation of nitric oxide to treat detrusor-external sphincter dyssynergia in spinal cord injury. Lancet 357:1964–1967CrossRefPubMed Mamas MA, Reynard JM, Brading AF (2001) Augmentation of nitric oxide to treat detrusor-external sphincter dyssynergia in spinal cord injury. Lancet 357:1964–1967CrossRefPubMed
9.
Zurück zum Zitat Andersson KE, Persson K (1993) Thel-arginine/nitric oxide pathway and non-adrenergic, non-cholinergic relaxation of the lower urinary tract. Gen Pharmacol 24:833–839CrossRefPubMed Andersson KE, Persson K (1993) Thel-arginine/nitric oxide pathway and non-adrenergic, non-cholinergic relaxation of the lower urinary tract. Gen Pharmacol 24:833–839CrossRefPubMed
10.
Zurück zum Zitat Persson K, Alm P, Johansson K, Larsson B, Andersson KE (1993) Nitric oxide synthase in pig lower urinary tract: immunohistochemistry, NADPH diaphorase histochemistry and functional effects. Br J Pharmacol 110:521–530PubMed Persson K, Alm P, Johansson K, Larsson B, Andersson KE (1993) Nitric oxide synthase in pig lower urinary tract: immunohistochemistry, NADPH diaphorase histochemistry and functional effects. Br J Pharmacol 110:521–530PubMed
11.
Zurück zum Zitat Haab F (2000) Discussion: nitric oxide and bladder overactivity. Urology 55:58–59CrossRef Haab F (2000) Discussion: nitric oxide and bladder overactivity. Urology 55:58–59CrossRef
12.
Zurück zum Zitat Fathian-Sabet B, Bloch W, Klotz T, Niggemann S, Jacobs G, Addicks K, Engelmann U (2001) Localization of constitutive nitric oxide synthase isoforms and the nitric oxide target enzyme soluble guanylyl cyclase in the human bladder. J Urol 165:1724–1729PubMed Fathian-Sabet B, Bloch W, Klotz T, Niggemann S, Jacobs G, Addicks K, Engelmann U (2001) Localization of constitutive nitric oxide synthase isoforms and the nitric oxide target enzyme soluble guanylyl cyclase in the human bladder. J Urol 165:1724–1729PubMed
13.
Zurück zum Zitat Bories PN, Bories C (1995) Nitrate determination in biological fluids by an enzymatic one-step assay with nitrate reductase. Clin Chem 41:904–907PubMed Bories PN, Bories C (1995) Nitrate determination in biological fluids by an enzymatic one-step assay with nitrate reductase. Clin Chem 41:904–907PubMed
14.
Zurück zum Zitat Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T (1993) Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 192:553–560PubMed Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T (1993) Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 192:553–560PubMed
15.
Zurück zum Zitat Kangawa K, Kitamura K, Minamino N, Eto T, Matsuo H (1996) Adrenomedullin: a new hypotensive peptide. J Hypertens 14:S105–S110 Kangawa K, Kitamura K, Minamino N, Eto T, Matsuo H (1996) Adrenomedullin: a new hypotensive peptide. J Hypertens 14:S105–S110
16.
Zurück zum Zitat Nishikimi T, Kitamura K, Saito Y, Shimada K, Ishimitsu T, Takamiya M, Kangawa K, Matsou H, Eto T, Omae T, Matsuoka H (1994) Clinical studies on the sites of production and clearance of circulating adrenomedullin in human subjects. Hypertension 24:600–604PubMed Nishikimi T, Kitamura K, Saito Y, Shimada K, Ishimitsu T, Takamiya M, Kangawa K, Matsou H, Eto T, Omae T, Matsuoka H (1994) Clinical studies on the sites of production and clearance of circulating adrenomedullin in human subjects. Hypertension 24:600–604PubMed
17.
Zurück zum Zitat Sugo S, Minamino N, Kangawa K, Miyamoto K, Kitamura K, Sakata J, Eto T, Matsuo H (1994) Endothelial cell actively synthesize and secrete adrenomedullin. Biochem Biophys Res Commun 201:1160–1166PubMed Sugo S, Minamino N, Kangawa K, Miyamoto K, Kitamura K, Sakata J, Eto T, Matsuo H (1994) Endothelial cell actively synthesize and secrete adrenomedullin. Biochem Biophys Res Commun 201:1160–1166PubMed
18.
Zurück zum Zitat Sugo S, Minamino N, Shoji H, Kangawa K, Kitamura K, Eto T, Matsuo H (1994) Production and secretion of adrenomedullin from vascular smooth muscle cells: augmented production by tumor necrosis factor-α. Biochem Biophys Res Commun 203:719–726PubMed Sugo S, Minamino N, Shoji H, Kangawa K, Kitamura K, Eto T, Matsuo H (1994) Production and secretion of adrenomedullin from vascular smooth muscle cells: augmented production by tumor necrosis factor-α. Biochem Biophys Res Commun 203:719–726PubMed
19.
Zurück zum Zitat Nishimura J, Seguchi H, Sakihara C, Kureishi Y, Yoshimura H, Kobayashi S, Kanaide H (1997) The relaxant effect of adrenomedullin on particular smooth muscles despite a general expression of its mRNA in smooth muscle, endothelial and epithelial cells. Br J Pharmacol 120:193–200PubMed Nishimura J, Seguchi H, Sakihara C, Kureishi Y, Yoshimura H, Kobayashi S, Kanaide H (1997) The relaxant effect of adrenomedullin on particular smooth muscles despite a general expression of its mRNA in smooth muscle, endothelial and epithelial cells. Br J Pharmacol 120:193–200PubMed
20.
Zurück zum Zitat Mant CT, Hudges RS (eds) (1991) High performance liquid chromotography of peptides and proteins. CRC Press Mant CT, Hudges RS (eds) (1991) High performance liquid chromotography of peptides and proteins. CRC Press
21.
Zurück zum Zitat Chung BH, Choı SK, Chang KC (1996) Effects of nitric oxide on detrusor relaxation. J Urol 155:2090–2093PubMed Chung BH, Choı SK, Chang KC (1996) Effects of nitric oxide on detrusor relaxation. J Urol 155:2090–2093PubMed
22.
Zurück zum Zitat Klarskov P (1987) Non-cholinergic, non-adrenergic nerve-mediated relaxation of pig and human detrusor muscle in vitro. Br J Urol 59:414–419PubMed Klarskov P (1987) Non-cholinergic, non-adrenergic nerve-mediated relaxation of pig and human detrusor muscle in vitro. Br J Urol 59:414–419PubMed
23.
Zurück zum Zitat James MJ, Birmingham AT, Hill SJ (1993) Partial mediation of nitric oxide of the relaxation of human isolated detrusor strips in response to electrical field stimulation. Br J Clin Pharmacol 35:366–372PubMed James MJ, Birmingham AT, Hill SJ (1993) Partial mediation of nitric oxide of the relaxation of human isolated detrusor strips in response to electrical field stimulation. Br J Clin Pharmacol 35:366–372PubMed
24.
Zurück zum Zitat Persson K, Andersson KE (1992) Nitric oxide and relaxation of pig lower urinary tract. Br J Pharmacol 106:416–422PubMed Persson K, Andersson KE (1992) Nitric oxide and relaxation of pig lower urinary tract. Br J Pharmacol 106:416–422PubMed
25.
Zurück zum Zitat Andersson KE (1993) Pharmacology of lower urinary tract smooth muscles and penile erectile tissue. Pharmacol Rev 45:253–308PubMed Andersson KE (1993) Pharmacology of lower urinary tract smooth muscles and penile erectile tissue. Pharmacol Rev 45:253–308PubMed
26.
Zurück zum Zitat Nishizawa S, Igawa Y, Okada N, Ohhashi T (1997) Capsaicin-induced nitric-oxide-dependent relaxation in isolated dog urethra. Eur J Pharmacol 335:211–219CrossRefPubMed Nishizawa S, Igawa Y, Okada N, Ohhashi T (1997) Capsaicin-induced nitric-oxide-dependent relaxation in isolated dog urethra. Eur J Pharmacol 335:211–219CrossRefPubMed
27.
Zurück zum Zitat Samson WK (1999) Adrenomedullin and the control of fluid and electrolyte homeostasis. Annu Rev Physiol 61:363–389PubMed Samson WK (1999) Adrenomedullin and the control of fluid and electrolyte homeostasis. Annu Rev Physiol 61:363–389PubMed
28.
Zurück zum Zitat Allaker RP, Zihni C, Kapas S (1999) An investigation into the antimicrobial effects of adrenomedullin on members of the skin, oral, respiratory tract and gut microflora. FEMS Immunol Med Microbiol 23:289–293CrossRefPubMed Allaker RP, Zihni C, Kapas S (1999) An investigation into the antimicrobial effects of adrenomedullin on members of the skin, oral, respiratory tract and gut microflora. FEMS Immunol Med Microbiol 23:289–293CrossRefPubMed
29.
Zurück zum Zitat Kamitani S, Asakawa M, Shimekake Y, Kuwasako K, Nakahara K, Sakata T (1999) The RAMP2/CRLR complex is a functional adrenomedullin receptor in human endothelial and vascular smooth muscle cells. FEBS Lett 44:111–114CrossRef Kamitani S, Asakawa M, Shimekake Y, Kuwasako K, Nakahara K, Sakata T (1999) The RAMP2/CRLR complex is a functional adrenomedullin receptor in human endothelial and vascular smooth muscle cells. FEBS Lett 44:111–114CrossRef
30.
Zurück zum Zitat Hattori Y, Mimura A, Akimoto K, Kasai K (1999) Transcriptional regulation of adrenomedullin in rat vascular smooth muscle cells. Mol Cell Endocrinol 147:143–147CrossRefPubMed Hattori Y, Mimura A, Akimoto K, Kasai K (1999) Transcriptional regulation of adrenomedullin in rat vascular smooth muscle cells. Mol Cell Endocrinol 147:143–147CrossRefPubMed
31.
Zurück zum Zitat Dotsch J, Hanze J, Knufer V, Steiss JO, Dittrich K, Seidel A, Rascher W (1998) Increased urinary adrenomedullin excretion in children with urinary-tract infection. Nephrol Dial Transplant 13:1686–1689CrossRefPubMed Dotsch J, Hanze J, Knufer V, Steiss JO, Dittrich K, Seidel A, Rascher W (1998) Increased urinary adrenomedullin excretion in children with urinary-tract infection. Nephrol Dial Transplant 13:1686–1689CrossRefPubMed
32.
Zurück zum Zitat Chini EN, Choi E, Grande JP, Burnett JC, Dousa TP (1995) Adrenomedullin suppresses mitogenesis in rat mesangial cells via cAMP pathway. Biochem Biophys Res Commun 215:868–873CrossRefPubMed Chini EN, Choi E, Grande JP, Burnett JC, Dousa TP (1995) Adrenomedullin suppresses mitogenesis in rat mesangial cells via cAMP pathway. Biochem Biophys Res Commun 215:868–873CrossRefPubMed
33.
Zurück zum Zitat Dotsch J, Schoof E, Schocklmann HO, Brune B, Knerr I, Repp R, Rascher W (2002) Nitric oxide increases adrenomedullin receptor function in rat mesangial cells. Kidney Int 61:1707–1713CrossRefPubMed Dotsch J, Schoof E, Schocklmann HO, Brune B, Knerr I, Repp R, Rascher W (2002) Nitric oxide increases adrenomedullin receptor function in rat mesangial cells. Kidney Int 61:1707–1713CrossRefPubMed
34.
Zurück zum Zitat Wein AJ (1998) Pharmacologic options for the overactive bladder. Urology 51:43–47PubMed Wein AJ (1998) Pharmacologic options for the overactive bladder. Urology 51:43–47PubMed
35.
Zurück zum Zitat Diokno AC, Lapides J (1972) Oxybutynin: a new drug with analgesic and anticholinergic properties. J Urol 108:307–309PubMed Diokno AC, Lapides J (1972) Oxybutynin: a new drug with analgesic and anticholinergic properties. J Urol 108:307–309PubMed
36.
Zurück zum Zitat Appell RA (1991) Oxybutynin. The clinical experience. Contemp Urol 3:60–67 Appell RA (1991) Oxybutynin. The clinical experience. Contemp Urol 3:60–67
37.
Zurück zum Zitat Aubert D, Cencig P, Royer M (1986) Treatment with oxybutynin hydrochloride of urinary incontinence and hyperactive bladder conditions in children. Ann Pediatr 33:629–634 Aubert D, Cencig P, Royer M (1986) Treatment with oxybutynin hydrochloride of urinary incontinence and hyperactive bladder conditions in children. Ann Pediatr 33:629–634
38.
Zurück zum Zitat Goessl C, Sauter T, Michael T, Berge B, Staehler M, Miller K (2000) Efficacy and tolerability of tolterodine in children with detrusor hyperreflexia. Urology 55:414–418CrossRefPubMed Goessl C, Sauter T, Michael T, Berge B, Staehler M, Miller K (2000) Efficacy and tolerability of tolterodine in children with detrusor hyperreflexia. Urology 55:414–418CrossRefPubMed
39.
Zurück zum Zitat Hjalmas K, Hellström AL, Morgen K, Lackgran G, Stenberg A (2001) The overactive bladder in children: a potential future indication for tolterodine. BJU Int 87:569–574CrossRefPubMed Hjalmas K, Hellström AL, Morgen K, Lackgran G, Stenberg A (2001) The overactive bladder in children: a potential future indication for tolterodine. BJU Int 87:569–574CrossRefPubMed
40.
Zurück zum Zitat Kjolseth D, Maddsen B, Knudsen LM, Norqaard JP, Djurhuus JC (1994) Biofeedback treatment of children and adults with idiopathic detrusor instability. Scand J Urol Nephrol 28:243–247PubMed Kjolseth D, Maddsen B, Knudsen LM, Norqaard JP, Djurhuus JC (1994) Biofeedback treatment of children and adults with idiopathic detrusor instability. Scand J Urol Nephrol 28:243–247PubMed
41.
Zurück zum Zitat Yamanishi T, Yasuda K, Murayama N, Sakakibara R, Uchiyama T, Ito H (2000) Biofeedback training for detrusor overactivity in children. J Urol 164:1686–1690PubMed Yamanishi T, Yasuda K, Murayama N, Sakakibara R, Uchiyama T, Ito H (2000) Biofeedback training for detrusor overactivity in children. J Urol 164:1686–1690PubMed
Metadaten
Titel
Adrenomedullin and nitric oxide in children with detrusor instability
verfasst von
Ayşe Balat
Kemal Sarıca
Mustafa Çekmen
Muhittin Yürekli
Faruk Yağcı
Ahmet Erbağcı
Publikationsdatum
01.05.2003
Verlag
Springer-Verlag
Erschienen in
Pediatric Nephrology / Ausgabe 5/2003
Print ISSN: 0931-041X
Elektronische ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-003-1125-1

Weitere Artikel der Ausgabe 5/2003

Pediatric Nephrology 5/2003 Zur Ausgabe

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.